Skip to main content

Table 5 Association of HbA1c/HDL-C with NAFLD after PSM

From: The HbA1c/HDL-C ratio as a screening indicator of NAFLD in U.S. adults: a cross-sectional NHANES analysis (2017–2020)

 

Model 1

Model 2

Model 3

OR (95%CI)

P

OR (95%CI)

P

OR (95%CI)

P

HbA1c/HDL-C

1.63 (1.55, 1.70)

< 0.001

1.32 (1.25, 1.39)

< 0.001

1.21 (1.14, 1.28)

< 0.001

HbA1c/HDL-C quartile

Q1

reference

reference

reference

Q2

2.05 (1.73, 2.43)

0.001

1.36 (1.13, 1.64)

0.001

1.29 (1.06, 1.57)

0.010

Q3

3.74 (3.15, 4.45)

< 0.001

1.88 (1.55, 2.29)

< 0.001

1.61 (1.31, 1.98)

< 0.001

Q4

7.61 (6.33, 9.15)

< 0.001

3.04 (2.44, 3.78)

< 0.001

1.61 (1.31, 1.98)

< 0.001

  1. Abbreviations: HbA1c/HDL-C ratio: hemoglobin A1c to high-density lipoprotein cholesterol ratio; NAFLD: nonalcoholic fatty liver disease; PSM: Propensity score matching; OR: Odds ratios; CI: confidence interval
  2. Model1 is adjusted for gender, age, race, PIR, education level. Model2 is further adjusted for BMI, smoking, diabetes, Coronary heart disease and hypertension based on Model1. Model3 is additionally adjusted for TG, TC, AST and ALT based on Model2